<http://webisa.webdatacommons.org/64905559>	<http://www.w3.org/ns/prov#value>	"I will frequently start a patient on olopatadine and a steroid that has minimal intraocular penetration so it is less likely to cause side effects such as cataracts and increased intraocular pressure." .
<http://webisa.webdatacommons.org/prov/481702051>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/64905559> .
<http://webisa.webdatacommons.org/64905559>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/64905559>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<optometricmanagement.com> .